HomeCompareSERKF vs MRK

SERKF vs MRK: Dividend Comparison 2026

SERKF yields 185.19% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SERKF wins by $76.95M in total portfolio value
10 years
SERKF
SERKF
● Live price
185.19%
Share price
$1.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.00M
Annual income
$37,339,999.80
Full SERKF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SERKF vs MRK

📍 SERKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSERKFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SERKF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SERKF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SERKF
Annual income on $10K today (after 15% tax)
$15,740.74/yr
After 10yr DRIP, annual income (after tax)
$31,738,999.83/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SERKF beats the other by $31,730,671.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SERKF + MRK for your $10,000?

SERKF: 50%MRK: 50%
100% MRK50/50100% SERKF
Portfolio after 10yr
$38.53M
Annual income
$18,674,898.97/yr
Blended yield
48.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SERKF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
4.0
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SERKF buys
0
MRK buys
0
No recent congressional trades found for SERKF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSERKFMRK
Forward yield185.19%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$77.00M$56.8K
Annual income after 10y$37,339,999.80$9,798.13
Total dividends collected$72.25M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: SERKF vs MRK ($10,000, DRIP)

YearSERKF PortfolioSERKF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$29,219$18,518.52$11,206$366.19+$18.0KSERKF
2$81,832$50,568.57$12,650$502.35+$69.2KSERKF
3$219,923$132,362.17$14,407$694.19+$205.5KSERKF
4$567,767$332,449.13$16,585$967.82+$551.2KSERKF
5$1,409,633$802,122.93$19,342$1,363.89+$1.39MSERKF
6$3,369,509$1,861,201.75$22,913$1,947.19+$3.35MSERKF
7$7,763,238$4,157,863.45$27,662$2,823.89+$7.74MSERKF
8$17,259,544$8,952,878.98$34,159$4,173.35+$17.23MSERKF
9$37,069,956$18,602,243.94$43,337$6,308.80+$37.03MSERKF
10$77,004,853$37,339,999.80$56,776$9,798.13+$76.95MSERKF

SERKF vs MRK: Complete Analysis 2026

SERKFStock

Serko Limited, a Software-as-a-Service technology business, provides online travel booking software solutions and expense management in New Zealand, Australia, North America, Europe, and internationally. The company offers Zeno Travel, an online booking tool that corporate travelers use to book flights, trains, hotels, rental cars, and airport transfers in line with their corporate travel policies; and Zeno Expense, which automates the process of corporate card and out-of-pocket expense submission, reconciliation, and reimbursement. It also provides Serko mobile, a mobile app for iPhones and android devices that gives users access to information and travel booking functionality on their mobile devices. Serko Limited was founded in 1994 and is headquartered in Auckland, New Zealand.

Full SERKF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SERKF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SERKF vs SCHDSERKF vs JEPISERKF vs OSERKF vs KOSERKF vs MAINSERKF vs JNJSERKF vs ABBVSERKF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.